Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01482975 · ClinicalTrials.gov registry record · NA
Tailored Interventions to Prevent Substance Abuse
A NA study, sponsored by University of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 4,158
- Enrollment target
NCT01482975: Completed NA study, sponsored by University of Rhode Island.
NCT01482975 is a NA study that has completed, run by University of Rhode Island. The registered enrollment target is 4,158 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01482975, a NA study, has completed, sponsored by University of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,158 participants
- Enrollment target
Study Summary
The overarching objective of this research is to prevent substance use in early adolescents through the use of innovative interactive interventions tailored to each individual's particular risk profile for using cigarettes and alcohol. The specific aims are: (1) To test the effectiveness of the computer-based profile-based tailored interventions to keep early adolescents smoke-free compared to a comparison group; (2) To test the effectiveness of the computer-based profile-based tailored interventions to keep early adolescents from using alcohol compared to a comparison group; and (3) To replicate findings that the tailored diet and physical activity interventions will be effective in reducing these two high risk behaviors as part of the comparison condition.
Primary Outcome
Percent reporting being smoke-free at 36 months
Interventions
- OTHER Tailored computer based intervention
- OTHER Tailored computer intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,158 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01482975 record still lists
NCT01482975 is an interventional study that assigns participants to a tested intervention. Its 4,158 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (196% higher).
The record links to 0 conditions, and to 2 interventions - of which Tailored computer based intervention is the first listed.
NCT01482975 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01482975 about?
NCT01482975 is a clinical study titled "Tailored Interventions to Prevent Substance Abuse". The overarching objective of this research is to prevent substance use in early adolescents through the use of innovative interactive interventions tailored to each individual's particular risk profile for using cigarettes and alcohol. The specific aims are: (1) To test the effectiveness of the comp...
What is the current status of trial NCT01482975?
This trial is currently completed. It is a NA study. The enrollment target is 4,158 participants. The study started on 2007-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01482975?
The interventions under investigation include: Tailored computer based intervention (OTHER), Tailored computer intervention (OTHER).
Who is sponsoring clinical trial NCT01482975?
This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01482975's enrollment target sits among peer trials
4,158 32nd of 2000 higher than 1,969 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia